Effects of nootropic drugs in a scopolam
β
R. Verloes; A.-M. Scotto; J. Gobert; E. WΓΌlfert
π
Article
π
1988
π
Springer
π
English
β 455 KB
Scopolamine (3 mg/kg IP) given before an acquisition trial, reduced the retention of a one-trial passive avoidance "step through" response in mice. A single administration of cholinergic agonists such as oxotremorine, BM-5, or arecoline, antagonized this amnesic effect of scopolamine. A significant